ロード中...
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
Programmed death 1 (PD-1, CD279) and programmed death ligand 1 (PD-L1, CD274) are involved in generating tumor-associated immunosuppression by suppression of T-cell proliferation and interleukin 2 (IL-2) production and immune checkpoint inhibitors targeting these molecules are showing compelling act...
保存先:
| 出版年: | Clin Neuropathol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dustri-Verlag Dr. Karl Feistle
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4766797/ https://ncbi.nlm.nih.gov/pubmed/26501438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300922 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|